MARKET

IIN

IIN

IntriCon
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.50
-0.02
-0.15%
Closed 16:00 07/01 EDT
OPEN
13.50
PREV CLOSE
13.52
HIGH
13.51
LOW
13.22
VOLUME
41.72K
TURNOVER
--
52 WEEK HIGH
23.84
52 WEEK LOW
9.84
MARKET CAP
119.09M
P/E (TTM)
-23.6179
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average IIN stock price target is 23.67 with a high estimate of 28.00 and a low estimate of 20.00.

EPS

IIN News

More
IntriCon Announces Scott Longval Who Was CFO And COO Has Been Appointed As President And CEO
Benzinga · 6d ago
IntriCon Announces Chief Executive Officer Transition
IntriCon Corporation (IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced that Scott Longval, who has served as the company’s Chief Financial Officer since July 2006 and Chief Ope
GlobeNewswire · 6d ago
Do Hedge Funds Love IntriCon Corporation (IIN)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter
Insider Monkey · 06/10 18:14
Stifel Maintains Buy on IntriCon, Lowers Price Target to $23
Stifel maintains IntriCon (NASDAQ:IIN) with a Buy and lowers the price target from $28 to $23.
Benzinga · 05/20 13:38
B. Riley FBR Maintains Buy on IntriCon, Raises Price Target to $28
B. Riley FBR maintains IntriCon (NASDAQ:IIN) with a Buy and raises the price target from $26.5 to $28.
Benzinga · 05/20 11:37
IntriCon Corporation (IIN) CEO Mark Gorder on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/20 03:33
IntriCon Q1 EPS $(0.220) May Not Compare To $(0.090) Estimate, Sales $21.500M Miss $23.280M Estimate
IntriCon (NASDAQ:IIN) reported quarterly losses of $(0.220) per share which missed the analyst consensus estimate of $(0.090) by 144.44 percent. This is a 375 percent decrease over earnings of $0.080 per share from the
Benzinga · 05/19 20:13
IntriCon Reports First Quarter 2020 Results
ARDEN HILLS, Minn., May 19, 2020 -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical.
GlobeNewswire · 05/19 20:12

Industry

Medical Equipment, Supplies & Distribution
+0.63%
Healthcare Equipment & Supplies
+0.48%

Hot Stocks

Symbol
Price
%Change

About IIN

IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market. The Company has facilities in Minnesota, California, Singapore, Indonesia, the United Kingdom and Germany, and operates through its subsidiaries. The Company's product offering includes a hearing aid discount program for health plans. This program is available around the nation to health insurers, including employer-sponsored, individual and Medicare plans. The Company also has various international value hearing aid (VHA) initiatives.
More

Webull offers kinds of IntriCon Corporation stock information, including NASDAQ:IIN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IIN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IIN stock methods without spending real money on the virtual paper trading platform.